慢性肾衰竭患者血浆中可溶性血管细胞黏附分子1的变化及意义被引量：1

The change of plasma soluble vascular cell adhension molecule-1 in chronic renal failure patients and its significance

暂未订购

导出

摘要目的观察慢性肾衰竭(chronic renal failure,CRF)患者血浆中可溶性血管细胞黏附分子1(soluble vascular cell adhesion molecule-l,sVCAM-1)的变化以及与C反应蛋白(C-reactive protein,CRP)和可溶性CD40配体(soluble CD40 ligand,sCD40L)之间的关系,探讨其在肾损伤和免疫异常中的可能作用。方法选择首都医科大学附属北京同仁医院肾内科收治的CRF未透析患者(CRF组)30例,血液透析(hemodialysis,HD)中心维持性血液透析(maintenance hemodialysis,MHD)3个月以上的尿毒症患者(HD组)30例,与患者年龄、性别相匹配的健康正常对照组20例。采用酶联免疫吸附法(ELISA)测定血浆sVCAM-1的水平,并进行相关因素分析,观察HD对sVCAM-1的影响。用方差分析和Pearson相关性分析进行统计学处理。结果 CRF组和HD组sVCAM-1、CRP和sCD40L水平均明显高于对照组(P<0.01),HD组sVCAM-1和sCD40L水平较CRF组升高(P<0.05);CRF组sVCAM-1水平与CRP和sCD40L之间成正相关(P<0.05),与血清肌酐(serum creatinine,SCr)之间成正相关(P<0.01),HD组sVCAM-1水平与CRP之间成正相关(P<0.01),与sCD40L和SCr之间无相关性(P>0.05);一次HD过程,HD后sVCAM-1水平较HD前明显升高(P<0.01)。结论 CRF患者血浆中sVCAM-1水平升高,HD患者更明显,可能与微炎症状态有关,可能参与CRF患者的肾损伤和免疫异常。 Objective To observe the change of plasma soluble vascular cell adhension molecule-1（sVCAM-1） and its relationship to C-reactive protein（CRP） and soluble CD40 ligand（sCD40L） in chronic renal failure（CRF） patients,and to explore their potential effects on renal injury and immunodeficiency.Methods We recruited 30 CRF patients without hemodialysis（CRF group） treated in the Department of Nephrology,Beijing TongRen Hospital of Capital Medical University,30 uremic patients on maintenance hemodialysis for more than 3 months（HD group） treated in the Dialysis Center of this hospital,and 20 healthy volunteers（normal control group） matched with the patients in age and gender.Plasma sVCAM-1 was measured by enzyme linked immunosorbent assay method.The relationship between sVCAM-1 and related factors,and the influence of hemodialysis on plasma sVCAM-1 were analyzed.ANOVA and Pearson correlation analysis were used for statistical analysis.Results Plasma sVCAM-1,CRP and sCD40L were significantly higher in CRF group and HD group than in the control group（P0.01）.Plasma sVCAM-1 and sCD40L were higher in HD group than in CRF group（P0.05）.In CRF group,sVCAM-1 level was positively correlated with CRP and sCD40L（P0.05）,and with serum creatinine（Scr）（P0.01）.In HD group,sVCAM-1 level was positively correlated with CRP（P0.01）,but had no correlations with Scr and sCD40L（P0.05）.After one HD session,plasma sVCAM-1 increased significantly,compared to that before the HD（P 0.01）.Conclusion Elevation of plasma sVCAM-1 occurs in CRF patients especially in those on hemodialysis,which may relate to the microinflammatory state and may also be involved in the renal injury and abnormal immune function in these patients.

作者姜立萍黄雯翟艳苓刘宁

机构地区首都医科大学附属北京同仁医院肾内科

出处《中国血液净化》 2011年第1期37-40,共4页 Chinese Journal of Blood Purification

关键词可溶性血管细胞黏附分子1 慢性肾衰竭血液透析炎症因子 Soluble vascular cell adhension molecule-1 Chronic renal failure Hemodialysis Inflammatory factors

分类号 R629.5 [医药卫生—整形外科]

引文网络
相关文献

参考文献11

1王晓丹（综述）,王晓亮（综述）,白云凯（审校）.VCAM-1与肾脏疾病[J].国际泌尿系统杂志,2007,27(3):390-395. 被引量：4
2滕丽新,张璟,曹佳.黏附分子与肾间质纤维化[J].国外医学（泌尿系统分册）,2002,22(2):121-125. 被引量：13
3Rabb B,Calderon E,Bittle PA,et al.Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients[J].Am J Kidney Dis,1996,27:239-243.
4Vaccaro F,Mule G,Cottone S,et al.Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein[J].Arch Med Res,2007,38:534-538.
5Musial K,Zwolin ska D,Polak-Jonkisz D,et al.Serum VCAM-1,ICAM-1,and L-selectin levels in children and young adults with chronic renal failure[J].Pediatr Nephrol,2005,20:52-55.
6张睿,王莉,李贵森,陈秀玲,何强,杨秀川.血液透析患者血清抵抗素水平与微炎症状态及脂代谢的关系[J].中国血液净化,2008,7(11):595-598. 被引量：6
7Kaysen GA.The microinflammatory state in uremia:causes and potential consequences[J].J Am Soc Nephrol,2001,12:1549-1557.
8Balla J,Magyar MT,Bereczki D,et al.Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease[J].Dis Markers,2006,22:133-140.
9Beckerle MC.Cell adhesion[M].Oxford:Oxford University Press,2002:1-36.
10Lin R,Liu J,Gan W,et al.C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells[J].Biol Pharm Bull,2004,27:1537-1543.

二级参考文献49

1Steppan CM, Bhat S, Bhat S, et al. The hormone resistin links obesity to diabetes. [J].Nature. 2001,409:307-312.
2Patel L, Buckels AC, Kinghom IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators[J]. Biochem Biophys Res Commun, 2003, 300:472- 476.
3Reilly MP, LehrkeM, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans[J]. Circulation, 2005,111 : 932-939.
4George AK. The microinflammatory state in uremia: cause and potential consequences[J]. J Am Soc Nephrol, 2001, 12:1549-1557.
5Kamyar K-Z, Joel D K, Gladys B, et al. A malnutritioninflammation score (MIS) is correlated with morbidity and mortal ity in maintenance hemodialysis patients[J].Am J of Kidney Dis, 2001,38:1251-1263.
6Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties[J]. Immunology, 2005, 174: 5789-5795.
7Kunaari A, Ukkola O, Paivansalo M, et al. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. [J] Olin Endocrinol Metab, 2006, 91: 2755-2760.
8Naoichi Sato, Kunihisa Kobayashi, Toyoshi Inoguchi, et al. Adenovirus -Mediated High Expression of Resistin Causes Dyslipidemia in Mice[J]. Endocrinology 2004,146(1):273-279.
9Greesbma K, Panayiotis A, Edward S, et al. Circulating Adiponectin and Resistin Levels in Relation to Metabolic Factors, Inflammatory Markers, and Vascular Reactivity in Diabetic Patients and Subjects at Risk for Diabetes. [J]. Diabetes Care 2004 27:24507-457.
10Burnett MS, Lee CW, Kinnaird TD, Stabile E, et al. The potential role of resistin in atherogenesis[J].Atherosclerosis, 2005,182:241-248.